Nephros (NEPH) EBIAT (2016 - 2025)
Historic EBIAT for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $337000.0.
- Nephros' EBIAT rose 8415.3% to $337000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 25941.87%. This contributed to the annual value of $74000.0 for FY2024, which is 10469.84% up from last year.
- Latest data reveals that Nephros reported EBIAT of $337000.0 as of Q3 2025, which was up 8415.3% from $237000.0 recorded in Q2 2025.
- In the past 5 years, Nephros' EBIAT registered a high of $558000.0 during Q1 2025, and its lowest value of -$3.2 million during Q3 2022.
- Its 5-year average for EBIAT is -$590684.2, with a median of -$433000.0 in 2023.
- As far as peak fluctuations go, Nephros' EBIAT tumbled by 26629.42% in 2022, and later soared by 43017.75% in 2025.
- Nephros' EBIAT (Quarter) stood at -$863000.0 in 2021, then rose by 1.74% to -$848000.0 in 2022, then rose by 22.88% to -$654000.0 in 2023, then soared by 153.36% to $349000.0 in 2024, then decreased by 3.44% to $337000.0 in 2025.
- Its EBIAT was $337000.0 in Q3 2025, compared to $237000.0 in Q2 2025 and $558000.0 in Q1 2025.